- Home
- CZNC vs JSPR Comparison
CZNC vs JSPR Comparison
Compare CZNC & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CZNC | JSPR |
|---|---|---|
| Founded | 1864 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 360.7M | 43.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CZNC | JSPR |
|---|---|---|
| Price | $21.40 | $1.52 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $22.00 | $18.13 |
| AVG Volume (30 Days) | 63.9K | ★ 1.1M |
| Earning Date | 01-22-2026 | 02-26-2026 |
| Dividend Yield | ★ 5.22% | N/A |
| EPS Growth | ★ 22.09 | N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | ★ $109,632,000.00 | N/A |
| Revenue This Year | $5.72 | N/A |
| Revenue Next Year | $7.18 | N/A |
| P/E Ratio | $12.24 | ★ N/A |
| Revenue Growth | ★ 7.59 | N/A |
| 52 Week Low | $18.02 | $1.39 |
| 52 Week High | $22.68 | $7.19 |
Technical Indicators
Market Signals| Indicator | CZNC | JSPR |
|---|---|---|
| Relative Strength Index (RSI) | 62.64 | 39.81 |
| Support Level | $19.77 | $1.48 |
| Resistance Level | $21.76 | $1.68 |
| Average True Range (ATR) | 0.46 | 0.14 |
| MACD | 0.11 | -0.03 |
| Stochastic Oscillator | 82.91 | 14.39 |
Price Performance
Historical ComparisonAbout CZNC Citizens & Northern Corp
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.